Early Disturbance of Lymphatic Transport as a Risk Factor for the Development of Breast-Cancer-Related Lymphedema.

Cancers (Basel) · 2023 · PMC10046360 · PMID 36980660

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In a study by Cariati [ 52 ], women receiving taxanes in the adjuvant setting were nearly twice as likely to develop BCRL as patients receiving non-taxane-based adjuvant chemotherapy, although this did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.